Cart
sales@molnova.com
Phospholipase A2 Activating Peptide
CAS No. 137314-60-4
Phospholipase A2 Activating Peptide( ——— )
Catalog No. M42207 CAS No. 137314-60-4
Phospholipase A2 Activating Peptide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhospholipase A2 Activating Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhospholipase A2 Activating Peptide
-
DescriptionPhospholipase A2 Activating Peptide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number137314-60-4
-
Formula Weight2330.8
-
Molecular FormulaC106H184N28O30
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pelargonidin3-O-[6-O...
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl）-β-D-glucoside
-
Lixisenatide
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
-
2-BFI hydrochloride
2-BFI hydrochloride is a high-affinity agonist of I2-imidazoline receptor. 2-BFI hydrochloride can be used in studies about protection against stroke and acute inflammatory immune disease.
